Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$3.58 - $6.3 $54,584 - $96,056
15,247 Added 85.46%
33,089 $143,000
Q4 2022

Feb 14, 2023

BUY
$3.18 - $7.0 $56,737 - $124,894
17,842 New
17,842 $124,000
Q2 2021

Aug 16, 2021

SELL
$5.65 - $7.47 $64,494 - $85,270
-11,415 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$5.61 - $12.01 $424,677 - $909,157
-75,700 Reduced 86.9%
11,415 $64,000
Q4 2020

Feb 16, 2021

BUY
$6.99 - $9.26 $608,933 - $806,684
87,115 New
87,115 $686,000
Q4 2018

Feb 14, 2019

SELL
$37.1 - $50.11 $213,250 - $288,032
-5,748 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$36.35 - $55.2 $208,939 - $317,289
5,748 New
5,748 $287,000
Q2 2018

Aug 14, 2018

SELL
$33.85 - $50.65 $184,753 - $276,447
-5,458 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$32.45 - $54.7 $177,112 - $298,552
5,458 New
5,458 $219,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $918M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.